Ardelyx (ARDX) Research & Development (2013 - 2026)
Ardelyx (ARDX) reported Research & Development of $26.1 million for Q2 2026, up 66.6% from $15.67 million a year earlier and up 29.3% from the prior quarter.
Powered by 
Analysis
Ardelyx (ARDX) Research & Development (2013 - 2026) Analysis & Trends
Over the twelve months ended Jun 30, 2026, Ardelyx's Research & Development came in at $87.21 million, up 46.4% year-over-year; for FY2025, it was $71.53 million, up 36.7% from FY2024.
- Research & Development has increased for three consecutive years, with a five-year compound annual growth rate of 1.9% (FY2020 to FY2025).
- By year, Research & Development came in at $52.32 million in FY2024 (+47.2%), $35.54 million in FY2023 (+1.0%), $35.2 million in FY2022 (-61.4%) and $91.14 million in FY2021 (+40.1%).
- The Q2 2026 figure ranks as the highest quarterly Research & Development since Q4 2016.
- Year over year, Research & Development has now increased in each of the last 12 quarters, with growth averaging 46.5% over the last eight quarters.
- The high point for year-over-year Research & Development in five years was Q3 2021 (growth of 93.6%); the low point was Q3 2022 (a decline of 68.5%).
- Per Business Quant data, the three quarters before Q2 2026 came in at $20.19 million (Q1 2026), $22.86 million (Q4 2025) and $18.07 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | R&D (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | 3.65 Bn |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | 2.34 Bn |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | 9.74 Bn |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | -2.85 Bn |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | -4.05 Bn |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | 1.87 Bn |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | 1.76 Bn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 2.81 Bn |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | 993.80 Mn |
| 10 | Ardelyx | 849.59 Mn | -177.71 Mn | 115.12 Mn | 26.10 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 26.10 Mn |
| Mar 31, 2026 | 20.19 Mn |
| Dec 31, 2025 | 22.86 Mn |
| Sep 30, 2025 | 18.07 Mn |
| Jun 30, 2025 | 15.67 Mn |
| Mar 31, 2025 | 14.94 Mn |
| Dec 31, 2024 | 13.67 Mn |
| Sep 30, 2024 | 15.31 Mn |
| Jun 30, 2024 | 12.76 Mn |
| Mar 31, 2024 | 10.58 Mn |
| Dec 31, 2023 | 9.52 Mn |
| Sep 30, 2023 | 8.64 Mn |
| Jun 30, 2023 | 8.28 Mn |
| Mar 31, 2023 | 9.09 Mn |
| Dec 31, 2022 | 9.14 Mn |
| Sep 30, 2022 | 7.47 Mn |
| Jun 30, 2022 | 9.74 Mn |
| Mar 31, 2022 | 8.85 Mn |
| Dec 31, 2021 | 20.97 Mn |
| Sep 30, 2021 | 23.70 Mn |
API Access
Ardelyx Research & Development API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=research-and-development&ticker=ARDX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "research-and-development", "ticker": "ARDX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=research-and-development&ticker=ARDX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();